{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:41:36Z","timestamp":1788169296300,"version":"build-2803163510"},"reference-count":196,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008235","name":"School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01233","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T05:22:17Z","timestamp":1598419337000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["The Role of Eicosanoids in Gynecological Malignancies"],"prefix":"10.3389","volume":"11","author":[{"given":"Paige G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Roque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mc Millan","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn C.","family":"Reader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cellsig.2009.09.012","article-title":"EP2 receptor mediated cAMP release is augmented by PGF 2 alpha activation of the FP receptor via the calcium-calmodulin pathway","volume":"22","author":"Abera","year":"2010","journal-title":"Cell. Signal."},{"key":"B2","doi-asserted-by":"crossref","unstructured":"The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid AdefuyeA. KatzA. A. SalesK. J. 2014","DOI":"10.1155\/2014\/748740"},{"key":"B3","unstructured":"NCT03152370: Preoperative Radiotherapy and E7046 in Rectum Cancer (PRAER 1)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.prostaglandins.2017.12.002","article-title":"Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway","volume":"134","author":"Ahn","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B5","unstructured":"Down-regulation of 20-HETE synthesis and signaling inhibits renal Adenocarcinoma cell proliferation and tumor growth AlexanianA. RufanovaV. A. MillerB. FlaschA. RomanR. J. SorokinA. 2009"},{"key":"B6","first-page":"163","article-title":"20-HETE-producing enzymes are up-regulated in human cancers","volume":"9","author":"Alexanian","year":"2012","journal-title":"Cancer Genomics Proteomics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-9-44","article-title":"Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer","volume":"9","author":"Alibek","year":"2014","journal-title":"Infect. Agents Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"30594","DOI":"10.18632\/oncotarget.25748","article-title":"Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer","volume":"9","author":"Almeida","year":"2018","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nri3777","article-title":"Epigenetic control of myeloid cell differentiation, identity and function","volume":"15","author":"\u00c1lvarez-Errico","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3892\/or.2019.6984","article-title":"Prostaglandin\u00a0D2 expression is prognostic in high\u2212grade serous ovarian cancer","volume":"41","author":"Alves","year":"2019","journal-title":"Oncol. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajog.2019.02.033","article-title":"Assessing research gaps and unmet needs in endometriosis","volume":"221","author":"As-Sanie","year":"2019","journal-title":"Am. J. Obstetrics Gynecol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1210\/en.2007-1168","article-title":"Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms","volume":"149","author":"Banu","year":"2008","journal-title":"Endocrinology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1210\/me.2009-0017","article-title":"Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1\/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms","volume":"23","author":"Banu","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ygyno.2006.08.008","article-title":"Cyclooxygenase inhibition and hyperthermia for the potentiation of the cytotoxic response in ovarian cancer cells","volume":"104","author":"Barnes","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/humrep\/del328","article-title":"Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase pathway","volume":"22","author":"Battersby","year":"2007","journal-title":"Hum. Reprod."},{"key":"B16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0090-6980(85)90128-5","article-title":"Formation of prostaglandins by ovarian carcinomas","volume":"29","author":"Bauknecht","year":"1985","journal-title":"Prostaglandins"},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13048-018-0389-9","article-title":"Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors","volume":"11","author":"Beeghly-Fadiel","year":"2018","journal-title":"J. Ovarian Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/whe.13.72","article-title":"Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer","volume":"10","author":"Black","year":"2014","journal-title":"Womens Health (Lond)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0175712","DOI":"10.1371\/journal.pone.0175712","article-title":"Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma","volume":"12","author":"Brencicova","year":"2017","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","article-title":"Thematic review series: proteomics. an integrated omics analysis of eicosanoid biology","volume":"50","author":"Buczynski","year":"2009","journal-title":"J. Lipid Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbcan.2014.01.004","article-title":"Tumor-induced perturbations of cytokines and immune cell networks","volume":"1845","author":"Burkholder","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1096\/fj.12-207597","article-title":"Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer","volume":"26","author":"Cai","year":"2012","journal-title":"FASEB J."},{"key":"B23","first-page":"557","article-title":"Vagina","volume-title":"Principles and Practice of Gynecologic Oncology","author":"Cardenes","year":"2013"},{"key":"B24","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1016\/S0021-9258(18)31383-8","article-title":"Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins","volume":"268","author":"Carroll","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0002-9440(10)62282-1","article-title":"Inhibitors of Cytochrome P450 4A Suppress Angiogenic Responses","volume":"166","author":"Chen","year":"2005","journal-title":"Am. J. Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1021\/bi102070w","article-title":"20-Iodo-14,15-Epoxyeicosa-8Z-enoyl-3-azidophenylsulfonamide: Photoaffinity Labeling of a 14,15-Epoxyeicosatrienoic Acid Receptor","volume":"50","author":"Chen","year":"2011","journal-title":"Biochemistry"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205175","article-title":"Discovery of novel multidrug resistance protein 4 (MRP4) inhibitors as active agents reducing resistance to anticancer drug 6-Mercaptopurine (6-MP) by structure and ligand-based virtual screening","volume":"13","author":"Chen","year":"2018","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.4155\/bio-2018-0173","article-title":"Quantification of eicosanoids and their metabolites in biological matrices: a review","volume":"10","author":"Chhonker","year":"2018","journal-title":"Bioanalysis"},{"key":"B29","article-title":"Functional analysis of PGE2 pathway members EP4 and MRP4 in ovarian cancer. [abstract]. In: Proceedings of the AACR Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment; Oct 1-4, 2017","volume-title":"Clin. Cancer Res.","author":"Ching","year":"2018"},{"key":"B30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10059-012-2297-y","article-title":"The Nuclear Receptor PPARs as important regulators of T-cell functions and autoimmune diseases","volume":"33","author":"Choi","year":"2012","journal-title":"Mol. Cells"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00137","article-title":"Tumor-associated macrophages contribute to tumor progression in ovarian cancer","volume":"4","author":"Colvin","year":"2014","journal-title":"Front. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1007\/s00018-017-2536-7","article-title":"Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting","volume":"74","author":"Contursi","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/B978-0-323-24098-7.00059-9","article-title":"Chapter 59 - Endometrial Cancer","volume-title":"Clinical Radiation Oncology","author":"Creutzberg","year":"2016"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5817","DOI":"10.2147\/OTT.S150456","article-title":"Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway","volume":"10","author":"Cui","year":"2017","journal-title":"Oncol. Targets Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/path.5160","article-title":"Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer","volume":"247","author":"Cummings","year":"2019","journal-title":"J. Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1158\/0008-5472.CAN-04-3814","article-title":"Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer","volume":"65","author":"Daikoku","year":"2005","journal-title":"Cancer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1158\/0008-5472.CAN-05-4063","article-title":"Cyclooxygenase-1 Is Overexpressed in Multiple Genetically Engineered Mouse Models of Epithelial Ovarian Cancer","volume":"66","author":"Daikoku","year":"2006","journal-title":"Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1158\/0008-5472.CAN-07-0828","article-title":"Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-\u03b4 Signaling in Epithelial Ovarian Cancer","volume":"67","author":"Daikoku","year":"2007","journal-title":"Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","article-title":"Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice","volume":"68","author":"Daikoku","year":"2008","journal-title":"Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.ajpath.2014.05.023","article-title":"Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways cooperatively exacerbate endometrial cancer","volume":"184","author":"Daikoku","year":"2014","journal-title":"Am. J. Pathol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102401","article-title":"The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication","volume":"20","author":"De Nola","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0002-9440(10)64912-7","article-title":"Expression of Cyclooxygenase 2 Is an Independent Prognostic Factor in Human Ovarian Carcinoma","volume":"160","author":"Denkert","year":"2002","journal-title":"Am. J. Pathol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1038\/sj.onc.1206920","article-title":"Induction of G0\/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference","volume":"22","author":"Denkert","year":"2003","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5528\/wjtm.v3.i1.1","article-title":"Epithelial ovarian cancer: An overview","volume":"3","author":"Desai","year":"2014","journal-title":"World J. Transl. Med."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e46","article-title":"Immunotherapy in endometrial cancer: new scenarios on the horizon","volume":"30","author":"Di Tucci","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1309\/15B66DQMFYYM78CJ","article-title":"NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma","volume":"125","author":"Dong","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1530\/REP-07-0514","article-title":"Two Pathways for Prostaglandin F2\u03b1 (PGF2\u03b1) Synthesis by the Primate Periovulatory Follicle","volume":"136","author":"Dozier","year":"2008","journal-title":"Reproduction"},{"key":"B48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.mehy.2004.06.031","article-title":"Lower expression of cyclooxygenase-2: is it associated with the development of borderline ovarian tumors","volume":"64","author":"Dursun","year":"2005","journal-title":"Med. Hypotheses"},{"key":"B49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/humrep\/deh054","article-title":"Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters","volume":"19","author":"Fagotti","year":"2004","journal-title":"Hum. Reprod."},{"key":"B50","doi-asserted-by":"publisher","first-page":"A50","DOI":"10.1158\/1557-3265.OVCA17-A50","article-title":"Abstract A50: EP4 receptor antagonism in paclitaxel-resistant ovarian clear cell carcinomas","volume":"24","author":"Fan","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/cncr.10736","article-title":"Cyclooxygenase-2 expression in endometrial carcinoma","volume":"95","author":"Ferrandina","year":"2002","journal-title":"Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/1940-6207.CAPR-11-0496","article-title":"The effect of HIV and HPV coinfection on Cervical COX-2 expression and systemic Prostaglandin E2 Levels","volume":"5","author":"Fitzgerald","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/01.pgp.0000228140.94339.db","article-title":"Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarrays","volume":"26","author":"Fons","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.thromres.2015.05.027","article-title":"Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease","volume":"136","author":"Friedman","year":"2015","journal-title":"Thromb. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s0014-2999(03)01485-7","article-title":"Prostaglandin F(2alpha) stimulation of cyclooxygenase-2 promoter activity by the FP(B) prostanoid receptor","volume":"465","author":"Fujino","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE signals through G-Protein-Coupled Receptor GPR75 (Gq) to affect vascular function and trigger hypertension","volume":"120","author":"Garcia","year":"2017","journal-title":"Circ. Res."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121970","article-title":"NGF-enhanced vasculogenic properties of epithelial ovarian cancer cells is reduced by inhibition of the COX-2\/PGE2 Signaling Axis","volume":"11","author":"Garrido","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1568","DOI":"10.1038\/cddis.2014.531","article-title":"Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity","volume":"5","author":"G\u00f6bel","year":"2014","journal-title":"Cell Death Dis."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e530s","article-title":"Eicosanoids and cancer","volume":"73","author":"Gomes","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1042\/0264-6021:3470441","article-title":"Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells","volume":"347","author":"Graness","year":"2000","journal-title":"Biochem. J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1124\/jpet.105.097782","article-title":"9L Gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-Hydroxy-N\u2032-(4-butyl-2-methylphenol) Formamidine (HET0016), a selective inhibitor of CYP4A","volume":"317","author":"Guo","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/jpet.106.115360","article-title":"Activation of vascular Endothelial growth factor through reactive Oxygen species mediates 20-Hydroxyeicosatetraenoic acid-induced endothelial cell Proliferation","volume":"321","author":"Guo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00280-011-1595-y","article-title":"Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival","volume":"68","author":"Guo","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B65","unstructured":"Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer GuptaR. A. TejadaL. V. TongB. J. DasS. K. MorrowJ. D. DeyS. K. 2003"},{"key":"B66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/1055-9965.EPI-18-0392","article-title":"Prediagnostic serum levels of fatty acid metabolites and risk of ovarian cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial","volume":"28","author":"Hada","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","article-title":"Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology","volume":"14","author":"Harizi","year":"2008","journal-title":"Trends Mol. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3892\/or.2013.2790","article-title":"Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor","volume":"30","author":"Hasegawa","year":"2013","journal-title":"Oncol. Rep."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079769","article-title":"High MUC2 expression in ovarian cancer is inversely associated with the M1\/M2 ratio of tumor-associated Macrophages and patient survival time","volume":"8","author":"He","year":"2013","journal-title":"PloS One"},{"key":"B70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF03003177","article-title":"Prostanoids and cyclic nucleotides in malignant and benign ovarian tumors","volume":"5","author":"Heinonen","year":"1988","journal-title":"Med. Oncol. Tumor Pharmacother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1158\/2326-6066.CIR-16-0400","article-title":"Constitutive IDO1 expression in human tumors is driven by Cyclooxygenase-2 and mediates intrinsic immune resistance","volume":"5","author":"Hennequart","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ygyno.2018.03.003","article-title":"Vulvar cancer: Two pathways with different localization and prognosis","volume":"149","author":"Hinten","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/CJI.0b013e318247a5e9","article-title":"Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4","volume":"35","author":"Holt","year":"2012","journal-title":"J. Immunother."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106405","article-title":"CYP-derived eicosanoids: implications for rheumatoid arthritis","volume":"146","author":"Hoxha","year":"2020","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061132","article-title":"Prostaglandin E2-induced COX-2 expressions via EP2 and EP4 signaling pathways in human LoVo colon cancer cells","volume":"18","author":"Hsu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1054\/bjoc.2001.2033","article-title":"Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine\/paracrine regulation of neoplastic cell function via EP2\/EP4 receptors","volume":"85","author":"Jabbour","year":"2001","journal-title":"Br. J. Cancer"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1210\/en.2005-0804","article-title":"A positive feedback loop that regulates cyclooxygenase-2 expression and prostaglandin F2alpha synthesis via the F-series-prostanoid receptor and extracellular signal-regulated kinase 1\/2 signaling pathway","volume":"146","author":"Jabbour","year":"2005","journal-title":"Endocrinology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.mce.2006.03.025","article-title":"Prostaglandin receptors are mediators of vascular function in endometrial pathologies","volume":"252","author":"Jabbour","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0163540","DOI":"10.1371\/journal.pone.0163540","article-title":"Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis promotes Angiogenesis in Endometriosis","volume":"11","author":"Jana","year":"2016","journal-title":"PloS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00731","article-title":"Epoxy-Oxylipins and Soluble Epoxide Hydrolase metabolic pathway as targets for NSAID-induced Gastroenteropathy and inflammation-associated Carcinogenesis","volume":"10","author":"Jones","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e25192","DOI":"10.1371\/journal.pone.0025192","article-title":"Anticancer effects of 15d-Prostaglandin-J2 in Wild-Type and Doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC","volume":"6","author":"Jong","year":"2011","journal-title":"PloS One"},{"key":"B83","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1600-0897.2011.01099.x","article-title":"Induction of cyclooxygenase (COX)-2 in human vaginal epithelial cells in response to TLR ligands and TNF-\u03b1","volume":"67","author":"Joseph","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1600-0897.2002.01075.x","article-title":"Uterine chemokines in reproductive physiology and pathology","volume":"47","author":"Kayisli","year":"2002","journal-title":"Am. J. Reprod. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejogrb.2013.01.006","article-title":"High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation","volume":"168","author":"Ke","year":"2013","journal-title":"Eur. J. Obstetrics Gynecol. Reprod. Biol."},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-11-8","article-title":"F-Prostaglandin receptor regulates endothelial cell function via fibroblast growth factor-2","volume":"11","author":"Keightley","year":"2010","journal-title":"BMC Cell Biol."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-488","article-title":"PGF2\u03b1-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer","volume":"10","author":"Keightley","year":"2010","journal-title":"BMC Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4021\/wjon2010.02.190w","article-title":"Expression of Cyclooxygenase-1 and 2 in Epithelial ovarian cancer: a Clinicopathologic study","volume":"1","author":"Khunnarong","year":"2010","journal-title":"World J. Oncol."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04888.x","article-title":"Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase","volume":"1171","author":"Kim","year":"2009","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/carcin\/bgp066","article-title":"Involvement of NF-\u03baB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein","volume":"30","author":"Kim","year":"2009","journal-title":"Carcinogenesis"},{"key":"B91","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.plefa.2005.04.014","article-title":"Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2","volume":"73","author":"Kino","year":"2005","journal-title":"Prostaglandins Leukotrienes Essent. Fatty Acids"},{"key":"B92","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/mco.2013.124","article-title":"The biology of uterine sarcomas: a review and update","volume":"1","author":"Kobayashi","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.prostaglandins.2014.11.003","article-title":"Multiple drug resistance-associated protein 4 (MRP4), Prostaglandin Transporter (PGT), and 15-Hydroxyprostaglandin Dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer","author":"Kochel","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.18632\/oncotarget.14145","article-title":"Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal\/triple negative breast cancer","volume":"8","author":"Kochel","year":"2017","journal-title":"Oncotarget"},{"key":"B95","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0952-3278(92)90089-2","article-title":"Eicosanoids production in endometriosis","volume":"45","author":"Koike","year":"1992","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1210\/en.2009-1318","article-title":"Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells","volume":"151","author":"Lau","year":"2010","journal-title":"Endocrinology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1196\/annals.1397.018","article-title":"Increased cyclooxygenase-2 expression associated with inflammatory cellular infiltration in elderly patient with vulvar cancer","author":"Lee","year":"2007","journal-title":"Signal Transduction Pathways, Part C: Cell Signaling in Health and Disease"},{"key":"B98","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1095\/biolreprod.112.100883","article-title":"Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms","volume":"88","author":"Lee","year":"2013","journal-title":"Biol. Reprod."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-40078-8","article-title":"Inflammatory cytokines and change of Th1\/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"B100","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12032-007-9016-0","article-title":"Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo","volume":"25","author":"Li","year":"2008","journal-title":"Med. Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12032-009-9179-y","article-title":"Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice","volume":"27","author":"Li","year":"2010","journal-title":"Med. Oncol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/ijms12010668","article-title":"Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo","volume":"12","author":"Li","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3892\/ol.2012.688","article-title":"Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo","volume":"4","author":"Li","year":"2012","journal-title":"Oncol. Lett."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3892\/ol.2012.929","article-title":"Effects of cyclooxygenase inhibitors on survival time in ovarian cancer xenograft-bearing mice","volume":"4","author":"Li","year":"2012","journal-title":"Oncol. Lett."},{"key":"B105","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3892\/ol.2012.1086","article-title":"Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts","volume":"5","author":"Li","year":"2013","journal-title":"Oncol. Lett."},{"key":"B106","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/modpathol.2008.187","article-title":"Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression","volume":"22","author":"Liu","year":"2009","journal-title":"Modern Pathol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.2147\/CMAR.S180334","article-title":"12-HETE facilitates cell survival by activating the integrin-linked kinase\/NF-\u03baB pathway in ovarian cancer","volume":"10","author":"Liu","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11010-018-3313-0","article-title":"MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma","volume":"448","author":"Liu","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1006\/jsre.1998.5312","article-title":"Prostaglandin I2Analogue, Iloprost, down regulates Mitogen-activated protein kinases of macrophages","volume":"76","author":"Lo","year":"1998","journal-title":"J. Surg. Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"8148","DOI":"10.1096\/fj.201802642R","article-title":"Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition","volume":"33","author":"Lu","year":"2019","journal-title":"FASEB J."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1172\/JCI27648","article-title":"Targeting tumor-associated macrophages as a novel strategy against breast cancer","volume":"116","author":"Luo","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B112","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ddstr.2006.07.001","article-title":"Tumor-associated macrophages (TAMs) as new target in anticancer therapy","volume":"3","author":"Mantovani","year":"2006","journal-title":"Drug Discovery Today: Ther. Strategies"},{"key":"B113","first-page":"3866","article-title":"\u039412-Prostaglandin-J2 is cytotoxic in human malignancies and synergizes with both cisplatin and radiation","volume":"56","author":"McClay","year":"1996","journal-title":"Cancer Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1210\/jcem.86.9.7856","article-title":"Expression, localization, and signaling of PGE(2) and EP2\/EP4 receptors in human nonpregnant endometrium across the menstrual cycle","volume":"86","author":"Milne","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B115","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1124\/jpet.106.107904","article-title":"Cyclooxygenase (COX)-1 and COX-2 participate in 5,6-epoxyeicosatrienoic acid-induced contraction of rabbit intralobar pulmonary arteries","volume":"321","author":"Moreland","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B116","article-title":"Vulva","volume-title":"Principles and Practive of Gynecologic Oncology","author":"Moroney","year":"2013"},{"key":"B117","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/107155760200900309","article-title":"Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells","volume":"9","author":"Munkarah","year":"2002","journal-title":"J. Soc Gynecol. Investig."},{"key":"B118","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ygyno.2011.08.002","article-title":"The role of the phosphatidylinositol 3-kinase (PI3K) pathway in the development and treatment of uterine cancer","volume":"123","author":"Naumann","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ajog.2015.03.044","article-title":"New insights in the pathophysiology of ovarian cancer and implications for screening and prevention","volume":"213","author":"Nezhat","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1182\/blood-2011-07-365825","article-title":"Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells","volume":"118","author":"Obermajer","year":"2011","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1073\/pnas.0735842100","article-title":"The cyclopentenone 15-deoxy-\u039412,14-prostaglandin J2 binds to and activates H-Ras","volume":"100","author":"Oliva","year":"2003","journal-title":"PNAS"},{"key":"B122","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/cas.14247","article-title":"Prostaglandin E2 receptor EP4 regulates cell migration through Orai1","volume":"111","author":"Osawa","year":"2020","journal-title":"Cancer Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.0802740","article-title":"Myeloid-derived suppressor cells: linking inflammation and cancer","volume":"182","author":"Ostrand-Rosenberg","year":"2009","journal-title":"J. Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1095\/biolreprod.110.089011","article-title":"MAPK14 cooperates with MAPK3\/1 to regulate endothelin-1-mediated prostaglandin synthase 2 induction and survival in leiomyoma but not in normal myometrial cells","volume":"84","author":"Oyeniran","year":"2011","journal-title":"Biol. Reprod."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1002\/cam4.1445","article-title":"Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses","volume":"7","author":"Painter","year":"2018","journal-title":"Cancer Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10555-010-9264-x","article-title":"Cytochrome P450-derived eicosanoids: the neglected pathway in cancer","volume":"29","author":"Panigrahy","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"B127","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10555-011-9315-y","article-title":"EET signaling in cancer","volume":"30","author":"Panigrahy","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1053\/j.seminoncol.2015.05.003","article-title":"Cancer and the Immune System: Basic Concepts and Targets for Intervention","volume":"42","author":"Pardoll","year":"2015","journal-title":"Semin. Oncol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbamcr.2015.11.011","article-title":"Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade","volume":"1863","author":"Park","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B130","doi-asserted-by":"publisher","first-page":"10675","DOI":"10.1074\/jbc.RA117.001297","article-title":"GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells","volume":"293","author":"Park","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112503","article-title":"Anti-cancer activity of Conyza blinii saponin against cervical carcinoma through MAPK\/TGF-\u03b2\/Nrf2 signaling pathways","volume":"112503","author":"Peng","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10555-007-9098-3","article-title":"Lipoxygenase metabolism: roles in tumor progression and survival","volume":"26","author":"Pidgeon","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B134","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ygyno.2014.12.029","article-title":"The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics","volume":"136","author":"Prahm","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/imt.11.20","article-title":"Immunity and immune suppression in human ovarian cancer","volume":"3","author":"Preston","year":"2011","journal-title":"Immunotherapy"},{"key":"B136","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0262-1746(86)90084-3","article-title":"Fatty acid composition and arachidonic acid metabolites in ascitic fluid of patients with ovarian cancer","volume":"22","author":"Punnonen","year":"1986","journal-title":"Prostaglandins Leukot. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/ERC-13-0450","article-title":"COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion","volume":"21","author":"Qiu","year":"2014","journal-title":"Endocrine-Related Cancer"},{"key":"B138","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.1073\/pnas.1616893114","article-title":"Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids","volume":"114","author":"Rand","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1194\/jlr.M094219","article-title":"Epoxyeicosatrienoic acid (EET)-stimulated angiogenesis is mediated by epoxy hydroxyeicosatrienoic acids (EHETs) formed from COX-2","volume":"60","author":"Rand","year":"2019","journal-title":"J Lipid Res"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-62","article-title":"Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression","volume":"5","author":"Rask","year":"2006","journal-title":"Mol. Cancer"},{"key":"B141","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10555-011-9303-2","article-title":"Prostaglandin E2 EP receptors as therapeutic targets in breast cancer","volume":"30","author":"Reader","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"B142","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1158\/1538-7445.AM2016-5169","article-title":"Abstract 5169: Functional studies of the prostaglandin E2 receptor EP4 in ovarian cancer","volume":"76","author":"Reader","year":"2016","journal-title":"Cancer Res."},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101590","article-title":"EP4 and Class III \u03b2-Tubulin expression in uterine smooth muscle tumors: implications for prognosis and treatment","volume":"11","author":"Reader","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0262-1746(85)90051-4","article-title":"Leiomyomas release prostaglandins","volume":"18","author":"Rees","year":"1985","journal-title":"Prostaglandins Leukot. Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13059-016-0956-6","article-title":"A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome","volume":"17","author":"Reinartz","year":"2016","journal-title":"Genome Biol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.celrep.2017.09.018","article-title":"Prostaglandin E2 leads to the acquisition of DNMT3A-dependent tolerogenic functions in human Myeloid-derived suppressor cells","volume":"21","author":"Rodr\u00edguez-Ubreva","year":"2017","journal-title":"Cell Rep."},{"key":"B147","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/1933719111432867","article-title":"Medical treatment of Uterine Leiomyoma","volume":"19","author":"Sabry","year":"2012","journal-title":"Reprod. Sci."},{"key":"B148","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1016\/j.ygyno.2007.07.023","article-title":"COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study","volume":"107","author":"Saldivar","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1530\/rep.0.1260559","article-title":"Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium","volume":"126","author":"Sales","year":"2003","journal-title":"Reproduction"},{"key":"B150","doi-asserted-by":"publisher","first-page":"493-496","DOI":"10.7196\/SAMJ.5532","article-title":"Inflammatory pathways in cervical cancer \u2013 the UCT contribution","volume":"102","author":"Sales","year":"2012","journal-title":"South Afr. Med. J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.1210\/jc.2004-0892","article-title":"Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway","volume":"89","author":"Sales","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1210\/me.2004-0022","article-title":"Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3\u2019,5\u2019-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1\/2 signaling pathways","volume":"18","author":"Sales","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"7707","DOI":"10.1158\/0008-5472.CAN-05-0101","article-title":"A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas","volume":"65","author":"Sales","year":"2005","journal-title":"Cancer Res."},{"key":"B154","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1210\/en.2006-1517","article-title":"F-prostanoid receptor regulation of fibroblast growth factor 2 signaling in endometrial adenocarcinoma cells","volume":"148","author":"Sales","year":"2007","journal-title":"Endocrinology"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1038\/sj.onc.1210883","article-title":"F-prostanoid receptor alters adhesion, morphology and migration of endometrial adenocarcinoma cells","volume":"27","author":"Sales","year":"2008","journal-title":"Oncogene"},{"key":"B156","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2008.01.016","article-title":"Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element","volume":"285","author":"Sales","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.bbamcr.2009.09.018","article-title":"Prostaglandin F2\u03b1-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium\u2013calcineurin\u2013NFAT pathway","volume":"1793","author":"Sales","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"B158","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1097\/SPV.0000000000000616","article-title":"EP4 Receptor Expression in Pelvic Organ Prolapse and Radiation-Induced Vaginal Stenosis: A Novel Therapeutic Target. American Urogyencologic Society 39th Annual Scientific Meeting, October 9-13, 2018","volume":"24","author":"Santayana","year":"2018"},{"key":"B159","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00001813-199404000-00002","article-title":"Prostaglandins in the treatment of cancer","volume":"5","author":"Sasaki","year":"1994","journal-title":"Anticancer Drugs"},{"key":"B160","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/0090-8258(91)90251-y","article-title":"Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2","volume":"41","author":"Sasaki","year":"1991","journal-title":"Gynecol. Oncol."},{"key":"B161","first-page":"3919","article-title":"Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo","volume":"59","author":"Sasaki","year":"1999","journal-title":"Cancer Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2011.02.015","article-title":"Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer","volume":"304","author":"Schulte","year":"2011","journal-title":"Cancer Lett."},{"key":"B163","doi-asserted-by":"publisher","first-page":"13840","DOI":"10.1074\/jbc.M111.317131","article-title":"Leukotriene B4 Receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2","volume":"287","author":"Seo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B164","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.prostaglandins.2018.06.001","article-title":"Drawing a link between the thromboxane A2 pathway and the role of platelets and tumor cells in ovarian cancer","volume":"137","author":"Serhan","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B165","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistic","volume":"69","author":"Siegel","year":"2019","journal-title":"CA: A Cancer J. Clin."},{"key":"B166","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1158\/0008-5472.CAN-06-4174","article-title":"Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells","volume":"67","author":"Sinha","year":"2007","journal-title":"Cancer Res."},{"key":"B167","doi-asserted-by":"publisher","first-page":"46700","DOI":"10.1074\/jbc.M408584200","article-title":"Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion","volume":"279","author":"Spinella","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B168","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1158\/1078-0432.CCR-04-0315","article-title":"Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells","volume":"10","author":"Spinella","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1097\/01.fjc.0000166255.12229.0d","article-title":"Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptor","author":"Spinella","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/med.1006","article-title":"Cyclopentenone prostaglandins: new insights on biological activities and cellular targets","volume":"21","author":"Straus","year":"2001","journal-title":"Med. Res. Rev."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3892\/etm.2018.6342","article-title":"Natural killer cells inhibit metastasis of ovarian carcinoma cells and show therapeutic effects in a murine model of ovarian cancer","volume":"16","author":"Sun","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"B172","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.canlet.2005.04.035","article-title":"Significance of cyclooxygenase 2 and MDR1\/P-glycoprotein coexpression in ovarian cancers","volume":"235","author":"Surowiak","year":"2006","journal-title":"Cancer Lett."},{"key":"B173","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3892\/ijo.2018.4561","article-title":"Novel SIRT1 inhibitor 15-deoxy-\u039412,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells","volume":"53","author":"Tae","year":"2018","journal-title":"Int. J. Oncol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1196\/annals.1397.018","article-title":"Increased cyclooxygenase-2 expression associated with inflammatory cellular infiltration in elderly patients with vulvar cancer","volume":"1095","author":"Taek","year":"2007","journal-title":"Signal Transduction Pathways Part C: Cell Signaling Health Dis."},{"key":"B175","doi-asserted-by":"publisher","first-page":"26208","DOI":"10.1074\/jbc.M201347200","article-title":"Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B","volume":"277","author":"Tamura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B176","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2009.06.010","article-title":"The role of prostacyclin in lung cancer","volume":"155","author":"Tennis","year":"2010","journal-title":"Trans. Res."},{"key":"B177","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.neo.7900119","article-title":"Heightened expression of Cyclooxygenase-2 and Peroxisome proliferator-activated receptor-\u03b4 in human Endometrial Adenocarcinoma","volume":"2","author":"Tong","year":"2000","journal-title":"Neoplasia"},{"key":"B178","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA: A Cancer J. Clin."},{"key":"B179","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ijc.24757","article-title":"Cyclooxygenase-2 inhibition inhibits PI3K\/AKT kinase activity in epithelial ovarian cancer","volume":"126","author":"Uddin","year":"2010","journal-title":"Int. J. Cancer"},{"key":"B180","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10555-018-9741-1","article-title":"Stress, inflammation, and eicosanoids: an emerging perspective","volume":"37","author":"Umamaheswaran","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"B181","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/078538902321012379","article-title":"The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma","volume":"34","author":"Uotila","year":"2002","journal-title":"Ann. Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1158\/0008-5472.CAN-09-0390","article-title":"Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma","volume":"69","author":"Wallace","year":"2009","journal-title":"Cancer Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1677\/JOE-10-0072","article-title":"Inflammatory events in endometrial adenocarcinoma","volume":"206","author":"Wallace","year":"2010","journal-title":"J. Endocrinol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"B185","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.fshw.2019.11.002","article-title":"Cytochrome P450 monooxygenase-mediated eicosanoid pathway: a potential mechanistic linkage between dietary fatty acid consumption and colon cancer risk","volume":"8","author":"Wang","year":"2019","journal-title":"Food Sci. Hum. Wellness"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/onc.2014.85","article-title":"Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration","volume":"34","author":"Wen","year":"2015","journal-title":"Oncogene"},{"key":"B187","doi-asserted-by":"publisher","first-page":"21353","DOI":"10.18632\/oncotarget.3860","article-title":"Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer","volume":"6","author":"Wilson","year":"2015","journal-title":"Oncotarget"},{"key":"B188","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1158\/2326-6066.CIR-15-0157","article-title":"Synergistic COX2 induction by IFN\u03b3 and TNF\u03b1 self-limits Type-1 immunity in the human tumor microenvironment","volume":"4","author":"Wong","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"B189","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.3892\/mmr.2018.8415","article-title":"Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP\u2212PKA\/PI3K\u2212Akt signaling pathway","volume":"17","author":"Xu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B190","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/0090-8258(83)90160-9","article-title":"Prostacyclin and thromboxane in ovarian cancer: effect of cytostatics and prostaglandin synthesis inhibitors","volume":"16","author":"Ylikorkala","year":"1983","journal-title":"Gynecol. Oncol."},{"key":"B191","first-page":"30","article-title":"Current etiopathogenetic views in vulvar cancer","volume":"39","author":"Zarcone","year":"1997","journal-title":"Panminerva Med."},{"key":"B192","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0006-291x(92)91619-2","article-title":"Regiospecific and enantioselective metabolism of 8,9-epoxyeicosatrienoic acid by cyclooxygenase","volume":"183","author":"Zhang","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1177\/0963689719890597","article-title":"Cyclooxygenase 2 promotes proliferation and invasion in ovarian cancer cells via the PGE2\/NF-\u03baB pathway","volume":"28","author":"Zhang","year":"2019","journal-title":"Cell Transplant."},{"key":"B194","doi-asserted-by":"publisher","first-page":"e12393","DOI":"10.1111\/cpr.12393","article-title":"Berberine inhibits the chemotherapy-induced repopulation by suppressing the arachidonic acid metabolic pathway and phosphorylation of FAK in ovarian cancer","volume":"50","author":"Zhao","year":"2017","journal-title":"Cell Prolif."},{"key":"B195","doi-asserted-by":"publisher","first-page":"982","DOI":"10.18632\/oncotarget.23140","article-title":"Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients","volume":"9","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"B196","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00418-017-1616-y","article-title":"Prostaglandin E2 receptor EP1 in healthy and diseased human endometrium","volume":"149","author":"Zhu","year":"2018","journal-title":"Histochem. Cell Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01233\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T09:46:34Z","timestamp":1617011194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01233\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":196,"alternative-id":["10.3389\/fphar.2020.01233"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01233","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"article-number":"1233"}}